Type 2 Diabetes

@article{Vijan2010Type2D,
  title={Type 2 Diabetes},
  author={Sandeep Vijan},
  journal={Annals of Internal Medicine},
  year={2010},
  volume={152},
  pages={ITC3-1}
}
  • S. Vijan
  • Published 2 March 2010
  • Medicine
  • Annals of Internal Medicine
This issue provides a clinical overview of type 2 diabetes focusing on prevention, diagnosis, treatment, practice improvement, and patient information. Readers can complete the accompanying CME quiz for 1.5 credits. Only ACP members and individual subscribers can access the electronic features of In the Clinic. Non-subscribers who wish to access this issue of In the Clinic can elect "Pay for View." Subscribers can receive 1.5 category 1 CME credits by completing the CME quiz that accompanies… 
New model of integrated care for uncontrolled type 2 diabetes in a retrospective, underserved adult population in the USA: a study protocol for an effectiveness and cost-effectiveness analysis
TLDR
Anticipated results will not only provide evidence about the impact of patient outcomes in underserved diabetic populations, but also give an idea of the cost-effectiveness of the new model and whether or not cost savings can be attained for patients, third-party payers and society.
Demographical Evaluation of Type 2 Diabetes Mellitus and Effect of Prescribed Anti Diabetic Drugs on Maintaining Optimal Glycemic Levels in Diabetic Patients : An Observational Study
TLDR
Evaluating Type 2 Diabetes Mellitus patients demographically and Effect of Prescribed Anti Diabetic Drugs in maintaining optimal glycemic levels in diabetic patients attending Medicine outpatient in the department of medicine at a tertiary care teaching hospital in Western Rajasthan found the majority of patients having poor glycemic control.
A Review on Diabetes and Its Management
The current approach to the treatment of both type 1 and type 2 diabetes is to achieve the best possible glucose control. Past clinical trials have shown that glycemia plays a key role in the
Diabetes Mellitus: Insights from Epidemiology, Biochemistry, Risk Factors, Diagnosis, Complications and Comprehensive Management
TLDR
This review focused on the biochemical aspects of diabetes, risk factors including both environmental and genetic, disease complications, diagnosis, management, and currently available medications for the treatment of diabetes.
Predictive and preventive models for diabetes prevention using clinical information in electronic health record
  • Ni Cao, Sisi Zeng, J. Chen
  • Medicine, Computer Science
    2015 IEEE International Conference on Bioinformatics and Biomedicine (BIBM)
  • 2015
TLDR
This work constructedabetes predictive models using electronic health record data, which could potentially have better preventive power than other diabetes predictive models known according to knowledge, and found 37 measurements significantly associated to diabetes, which are not directly related to diabetes diagnosis criteria.
The effects of bariatric surgery on dyslipidemia and insulin resistance in overweight patients with or without type 2 diabetes: a systematic review and network meta-analysis.
  • De-feng Liu, Zheng-ye Ma, Jing Dong
  • Medicine
    Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery
  • 2021
Identification of Genetic Loci Associated with Risk for Type-2 Diabetes Mellitus (T2DM) in Indians from Rajasthan
The global epidemic of type 2 diabetes is increasing at an alarming rate in both developed and developing countries around the world. The emerging pandemic is driven by the combined effects of
Diabetes and Heart Failure: Multi-Omics Approaches
TLDR
Recent omics-driven discoveries in the diagnosis and treatment of type 2 diabetes and heart failure with focus on the common molecular mechanisms are reviewed.
The representativeness of eligible patients in type 2 diabetes trials: a case study using GIST 2.0
TLDR
The common low representativeness of type 2 diabetes trials could be attributed to specific study design requirements of trials or safety concerns, and this work contributes a method for increasing the transparency of the represent ativeness of clinical trials.
...
...

References

SHOWING 1-10 OF 10 REFERENCES
Screening for Type 2 Diabetes Mellitus: A Cost-Effectiveness Analysis
TLDR
A new cost-effectiveness analysis is performed to compare universal diabetes screening (universal screening) and diabetes screening targeted to patients with hypertension (targeted screening), and the finding that intensive control of hypertension is beneficial among people with diabetes is supported.
ESTIMATING THE MICROVASCULAR BENEFITS OF SCREENING FOR TYPE 2 DIABETES MELLITUS
TLDR
Morbidity from type 2 diabetes can be most effectively reduced by developing ways to modestly improve the glycemic control of known diabetic subjects, particularly those with high A1c's and early onset of disease.
Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus.
TLDR
Annual retinal screening for all patients with type 2 diabetes without previously detected retinopathy may not be warranted on the basis of cost-effectiveness, and tailoring recommendations to individual circumstances may be preferable.
Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study
TLDR
Diet and/or exercise interventions led to a significant decrease in the incidence of diabetes over a 6-year period among those with IGT, and thereby reduce the overall incidence of diabetic complications.
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
TLDR
Lifestyle changes and treatment with metformin both reduced the incidence of diabetes in persons at high risk and the lifestyle intervention was more effective than meetformin.
The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease
TLDR
This trial does not provide evidence to support the use of aspirin or antioxidants in primary prevention of cardiovascular events and mortality in the population with diabetes studied.
Glycemic control and type 2 diabetes mellitus : the optimal hemoglobin A 1 c targets . A guidance statement from the American College of Physicians
  • 2007
Go to www.annals.org/intheclinic/ to obtain up to 1.5 CME credits, to view explanations for correct answers
  • Questions are largely from the ACP's Medical Knowledge Self-Assessment Program